Arthur W Douville, MD
Neurology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Douville’s office at (650) 967-1515 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A25104 · Current
Licensed to practise in California · since 1973 · expires 2028-06-30 · University of Kansas School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$77,301
Medicare paid this office $77,301 for 306 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 185 | $30,500 | $105 |
| New patient visit (60+ min) | 102 | $18,440 | $181 |
| Long return visit (40+ min) | 91 | $16,960 | $149 |
| Short return visit (20+ min) | 100 | $8,437 | $73 |
Who their Medicare patients are
306 Original Medicare patients in 2024. Average age 79 · Women 44% · Health risk score 1.31. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Coronary heart disease 34% · Atrial fibrillation 28% · Chronic kidney disease 24% · Dementia 24% · Diabetes 23% · Stroke 23% · Depression 21% · Cancer 19% · Heart failure 16% · COPD 11%.
The office billed $124,095, Medicare allowed $105,799 and paid $77,301; for 650 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 306 | 650 | 79 | 1.31 | $124,095 | $77,301 |
| 2023 | 294 | 593 | 79 | 1.20 | $110,146 | $69,166 |
| 2022 | 382 | 755 | 78 | 1.24 | $151,872 | $94,500 |
| 2021 | 323 | 731 | 78 | 1.15 | $141,885 | $93,110 |
| 2020 | 260 | 515 | 77 | 1.24 | $82,147 | $52,334 |
| 2019 | 214 | 500 | 77 | 1.09 | $82,339 | $53,527 |
| 2018 | 144 | 224 | 76 | 1.26 | $30,764 | $18,931 |
| 2017 | 494 | 1,269 | 78 | 1.30 | $192,895 | $115,327 |
| 2016 | 456 | 1,231 | 77 | 1.28 | $178,757 | $110,453 |
| 2015 | 410 | 1,098 | 77 | 1.33 | $153,199 | $98,515 |
| 2014 | 318 | 630 | 76 | 1.20 | $83,758 | $57,615 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 167 | $26,200 | $106 |
| New patient visit (60+ min) | 96 | $17,242 | $180 |
| Long return visit (40+ min) | 81 | $14,895 | $143 |
| Short return visit (20+ min) | 86 | $8,550 | $71 |
2022: 5 services
| New patient visit (60+ min) | 175 | $31,987 | $183 |
| Return visit (30+ min) | 176 | $27,408 | $102 |
| Long return visit (40+ min) | 109 | $20,754 | $153 |
| Short return visit (20+ min) | 94 | $8,171 | $74 |
| New patient visit (45+ min) | 12 | $1,729 | $144 |
2021: 5 services
| Return visit (30+ min) | 185 | $33,462 | $111 |
| New patient visit (60+ min) | 148 | $27,638 | $187 |
| Long return visit (40+ min) | 94 | $18,286 | $156 |
| Short return visit (20+ min) | 65 | $5,492 | $75 |
| Muscle electrical test | 13 | $1,029 | $69 |
2020: 6 services
| New patient visit (60+ min) | 104 | $18,503 | $178 |
| Return visit (30+ min) | 130 | $17,124 | $89 |
| Short return visit (20+ min) | 76 | $5,704 | $62 |
| Long return visit (40+ min) | 16 | $1,993 | $117 |
| New patient visit (45+ min) | 12 | $1,613 | $134 |
| Short return visit | 14 | $469 | $34 |
2019: 5 services
| Return visit (30+ min) | 136 | $23,087 | $93 |
| New patient visit (60+ min) | 90 | $15,883 | $176 |
| Long return visit (40+ min) | 37 | $4,822 | $121 |
| Short return visit (20+ min) | 57 | $4,356 | $61 |
| New patient visit (45+ min) | 12 | $1,649 | $137 |
2018: 4 services
| Return visit (30+ min) | 92 | $10,857 | $87 |
| Short return visit (20+ min) | 54 | $3,729 | $57 |
| New patient visit (60+ min) | 12 | $2,062 | $172 |
| Long return visit (40+ min) | 12 | $1,474 | $113 |
2017: 9 services
| Return visit (30+ min) | 319 | $51,060 | $84 |
| New patient visit (60+ min) | 163 | $26,280 | $161 |
| Short return visit (20+ min) | 171 | $12,843 | $54 |
| Long return visit (40+ min) | 72 | $9,907 | $113 |
| New patient visit (45+ min) | 22 | $2,594 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,482 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,346 | $156 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,122 | $57 |
| Muscle electrical test | 11 | $609 | $51 |
2016: 7 services
| Return visit (30+ min) | 301 | $51,226 | $84 |
| New patient visit (60+ min) | 138 | $22,230 | $161 |
| Short return visit (20+ min) | 176 | $14,264 | $55 |
| Long return visit (40+ min) | 62 | $9,076 | $119 |
| New patient visit (45+ min) | 26 | $3,270 | $126 |
| Nerve test | 17 | $1,660 | $98 |
| Muscle electrical test | 11 | $654 | $54 |
2015: 7 services
| Return visit (30+ min) | 219 | $36,261 | $92 |
| Short return visit (20+ min) | 223 | $24,363 | $62 |
| New patient visit (60+ min) | 104 | $18,240 | $175 |
| New patient visit (45+ min) | 74 | $9,488 | $128 |
| Long return visit (40+ min) | 36 | $5,062 | $127 |
| Short return visit | 39 | $1,476 | $33 |
| Nerve test | 12 | $951 | $79 |
2014: 6 services
| Return visit (30+ min) | 137 | $16,750 | $95 |
| Short return visit (20+ min) | 183 | $16,369 | $64 |
| New patient visit (60+ min) | 58 | $10,245 | $177 |
| New patient visit (45+ min) | 41 | $5,797 | $141 |
| Long return visit (40+ min) | 22 | $2,913 | $127 |
| Short return visit | 26 | $1,065 | $38 |
Drugs they prescribed that Part D paid
$78,364
Pharmacies billed $78,364 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (36 of 879) in 2024. A higher opioid share than 9 in 10 peers; the typical neurology clinician is at 0%.
859 generic and 20 brand-name prescriptions · $78,364 in drug cost · 26 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Memantine | 66 | $8,544 | $129 |
| Duloxetine | 36 | $2,906 | $81 |
| Rivastigmine | 14 | $2,285 | $163 |
| Donepezil | 105 | $1,225 | $12 |
| Carbidopa-Levodopa | 42 | $1,197 | $28 |
See all 21 drugs
| Memantine | 66 | $8,544 | $129 |
| Duloxetine | 36 | $2,906 | $81 |
| Rivastigmine | 14 | $2,285 | $163 |
| Donepezil | 105 | $1,225 | $12 |
| Carbidopa-Levodopa | 42 | $1,197 | $28 |
| Levetiracetam | 31 | $798 | $26 |
| Primidone | 47 | $771 | $16 |
| Lacosamide | 16 | $616 | $39 |
| Baclofen | 23 | $610 | $27 |
| Gabapentin | 35 | $523 | $15 |
| Clonazepam | 29 | $503 | $17 |
| Propranolol Hcl Er | 13 | $488 | $38 |
| Escitalopram | 24 | $476 | $20 |
| Lamotrigine | 18 | $410 | $23 |
| Ropinirole | 15 | $395 | $26 |
| Pyridostigmine | 12 | $339 | $28 |
| Hydrocodone-Acetaminophen | 22 | $332 | $15 |
| Quetiapine | 14 | $160 | $11 |
| Dextroamphetamine-Amphetamine | 11 | $140 | $13 |
| Trazodone | 11 | $61 | $6 |
| Alprazolam | 11 | $15 | $1 |
Year by year
| 2024 | 879 | 170 | 4% (36) | 2% | $78,364 |
| 2023 | 877 | 158 | 3% (25) | None | $107,624 |
| 2022 | 924 | 189 | 4% (37) | None | $186,266 |
| 2021 | 845 | 155 | 6% (54) | 6% | $149,610 |
| 2020 | 867 | 119 | 8% (65) | 5% | $151,695 |
| 2019 | 686 | 100 | 4% (27) | 8% | $137,612 |
| 2018 | 950 | 148 | 8% (72) | None | $233,857 |
| 2017 | 1,859 | 223 | 8% (144) | None | $334,436 |
| 2016 | 1,726 | 208 | 8% (137) | 6% | $187,719 |
| 2015 | 1,532 | 200 | 10% (153) | 11% | $227,727 |
| 2014 | 629 | 153 | 10% (63) | 9% | $65,228 |
| 2013 | 18 | 11 | None | None | $1,841 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Memantine | 63 | $5,096 | $81 |
| Levetiracetam | 20 | $3,733 | $187 |
| Duloxetine | 28 | $3,475 | $124 |
| Lacosamide | 12 | $3,047 | $254 |
| Donepezil | 110 | $1,986 | $18 |
| Carbidopa-Levodopa | 37 | $1,360 | $37 |
| Acetazolamide | 12 | $1,062 | $88 |
| Gabapentin | 46 | $1,057 | $23 |
| Propranolol Hcl Er | 15 | $775 | $52 |
| Lamotrigine | 21 | $775 | $37 |
| Baclofen | 19 | $755 | $40 |
| Olanzapine | 12 | $554 | $46 |
| Carbidopa-Levodopa Er | 12 | $546 | $46 |
| Primidone | 35 | $540 | $15 |
| Clonazepam | 41 | $522 | $13 |
| Escitalopram | 19 | $467 | $25 |
| Hydrocodone-Acetaminophen | 21 | $394 | $19 |
| Ropinirole | 11 | $313 | $28 |
| Prednisone | 20 | $250 | $12 |
| Sertraline | 16 | $202 | $13 |
| Zolpidem | 14 | $167 | $12 |
| Divalproex | 11 | $160 | $15 |
| Methylprednisolone | 11 | $135 | $12 |
2022: 25 drugs
| Vimpat | 12 | $13,084 | $1,090 |
| Modafinil | 11 | $5,904 | $537 |
| Mexiletine | 12 | $3,858 | $322 |
| Levetiracetam | 26 | $3,573 | $137 |
| Memantine | 29 | $1,907 | $66 |
| Rivastigmine | 13 | $1,637 | $126 |
| Gabapentin | 68 | $1,498 | $22 |
| Duloxetine | 38 | $1,495 | $39 |
| Carbidopa-Levodopa | 29 | $1,249 | $43 |
| Donepezil | 87 | $1,031 | $12 |
| Ropinirole | 16 | $666 | $42 |
| Oxcarbazepine | 11 | $652 | $59 |
| Hydrocodone-Acetaminophen | 27 | $642 | $24 |
| Zonisamide | 18 | $598 | $33 |
| Lamotrigine | 23 | $527 | $23 |
| Propranolol Hcl Er | 16 | $488 | $31 |
| Clonazepam | 51 | $382 | $7 |
| Escitalopram | 13 | $365 | $28 |
| Primidone | 21 | $290 | $14 |
| Quetiapine | 15 | $239 | $16 |
| Prednisone | 22 | $233 | $11 |
| Verapamil Er | 15 | $180 | $12 |
| Methylprednisolone | 11 | $154 | $14 |
| Dextroamphetamine-Amphetamine | 11 | $117 | $11 |
| Zolpidem | 12 | $83 | $7 |
2021: 21 drugs
| Avonex | 13 | $100,229 | $7,710 |
| Vimpat | 14 | $14,056 | $1,004 |
| Rivastigmine | 22 | $2,215 | $101 |
| Levetiracetam | 36 | $2,207 | $61 |
| Gabapentin | 71 | $1,705 | $24 |
| Carbidopa-Levodopa | 26 | $1,382 | $53 |
| Hydrocodone-Acetaminophen | 31 | $1,274 | $41 |
| Propranolol Hcl Er | 18 | $1,050 | $58 |
| Memantine | 11 | $947 | $86 |
| Donepezil | 66 | $866 | $13 |
| Pregabalin | 15 | $665 | $44 |
| Clonazepam | 61 | $475 | $8 |
| Primidone | 25 | $428 | $17 |
| Quetiapine | 21 | $310 | $15 |
| Duloxetine | 19 | $292 | $15 |
| Prednisone | 20 | $267 | $13 |
| Baclofen | 14 | $251 | $18 |
| Sumatriptan | 17 | $243 | $14 |
| Escitalopram | 12 | $220 | $18 |
| Lamotrigine | 15 | $208 | $14 |
| Diazepam | 14 | $17 | $1 |
2020: 25 drugs
| Avonex | 13 | $98,264 | $7,559 |
| Gabapentin | 70 | $1,837 | $26 |
| Hydrocodone-Acetaminophen | 45 | $1,421 | $32 |
| Carbidopa-Levodopa | 22 | $1,265 | $57 |
| Levetiracetam | 26 | $1,092 | $42 |
| Propranolol Hcl Er | 13 | $1,078 | $83 |
| Donepezil | 60 | $886 | $15 |
| Pregabalin | 21 | $863 | $41 |
| Pramipexole Dihydrochloride | 15 | $834 | $56 |
| Duloxetine | 24 | $687 | $29 |
| Clonazepam | 62 | $518 | $8 |
| Sumatriptan | 22 | $351 | $16 |
| Quetiapine | 21 | $291 | $14 |
| Mirtazapine | 15 | $287 | $19 |
| Baclofen | 16 | $285 | $18 |
| Topiramate | 12 | $244 | $20 |
| Lamotrigine | 13 | $215 | $17 |
| Primidone | 12 | $191 | $16 |
| Paroxetine | 16 | $186 | $12 |
| Oxycodone | 12 | $144 | $12 |
| Prednisone | 12 | $140 | $12 |
| Alprazolam | 15 | $60 | $4 |
| Ibuprofen | 11 | $48 | $4 |
| Cyclobenzaprine | 11 | $44 | $4 |
| Metoprolol | 13 | $26 | $2 |
2019: 21 drugs
| Lyrica | 12 | $9,807 | $817 |
| Gabapentin | 61 | $1,963 | $32 |
| Carbidopa-Levodopa | 14 | $901 | $64 |
| Duloxetine | 17 | $827 | $49 |
| Levetiracetam | 23 | $778 | $34 |
| Baclofen | 24 | $690 | $29 |
| Donepezil | 32 | $556 | $17 |
| Lamotrigine | 26 | $507 | $20 |
| Zonisamide | 12 | $380 | $32 |
| Amitriptyline | 12 | $348 | $29 |
| Propranolol | 15 | $316 | $21 |
| Clonazepam | 45 | $278 | $6 |
| Topiramate | 12 | $278 | $23 |
| Hydrocodone-Acetaminophen | 11 | $219 | $20 |
| Paroxetine | 14 | $207 | $15 |
| Quetiapine | 13 | $172 | $13 |
| Sumatriptan | 15 | $152 | $10 |
| Trazodone | 12 | $119 | $10 |
| Temazepam | 15 | $112 | $7 |
| Cyclobenzaprine | 15 | $110 | $7 |
| Alprazolam | 16 | $95 | $6 |
2018: 32 drugs
| Avonex | 13 | $89,166 | $6,859 |
| Lyrica | 11 | $12,226 | $1,111 |
| Vimpat | 11 | $11,679 | $1,062 |
| Gabapentin | 89 | $3,059 | $34 |
| Acetazolamide | 18 | $2,029 | $113 |
| Memantine | 21 | $1,272 | $61 |
| Donepezil | 73 | $1,098 | $15 |
| Levetiracetam | 39 | $959 | $25 |
| Carbidopa-Levodopa | 16 | $767 | $48 |
| Oxcarbazepine | 16 | $766 | $48 |
| Midodrine | 11 | $731 | $66 |
| Lamotrigine | 32 | $622 | $19 |
| Hydrocodone-Acetaminophen | 24 | $502 | $21 |
| Topiramate | 18 | $451 | $25 |
| Baclofen | 17 | $449 | $26 |
| Escitalopram | 39 | $440 | $11 |
| Nortriptyline | 13 | $376 | $29 |
| Sumatriptan | 23 | $364 | $16 |
| Zonisamide | 18 | $338 | $19 |
| Atorvastatin | 19 | $313 | $16 |
| Temazepam | 13 | $259 | $20 |
| Mirtazapine | 11 | $250 | $23 |
| Duloxetine | 12 | $239 | $20 |
| Oxycodone-Acetaminophen | 15 | $219 | $15 |
| Clopidogrel | 17 | $198 | $12 |
| Propranolol | 12 | $198 | $17 |
| Clonazepam | 35 | $188 | $5 |
| Methadone | 12 | $139 | $12 |
| Alprazolam | 16 | $117 | $7 |
| Lorazepam | 12 | $93 | $8 |
| Zolpidem | 14 | $75 | $5 |
| Estradiol | 12 | $65 | $5 |
2017: 50 drugs
| Avonex | 13 | $81,690 | $6,284 |
| Copaxone | 11 | $69,286 | $6,299 |
| Lyrica | 16 | $12,503 | $781 |
| Gabapentin | 153 | $4,212 | $28 |
| Memantine | 46 | $3,442 | $75 |
| Acetazolamide | 24 | $3,087 | $129 |
| Carbidopa-Levodopa | 56 | $2,719 | $49 |
| Oxycontin | 12 | $2,412 | $201 |
| Oxycodone-Acetaminophen | 45 | $2,129 | $47 |
| Donepezil | 169 | $1,746 | $10 |
| Levetiracetam | 60 | $1,662 | $28 |
| Divalproex Sodium Er | 15 | $1,644 | $110 |
| Esomeprazole Magnesium | 12 | $1,484 | $124 |
| Carbidopa-Levodopa Er | 20 | $1,471 | $74 |
| Amantadine | 11 | $1,328 | $121 |
| Phenytoin Sodium Extended | 26 | $1,226 | $47 |
| Protriptyline | 18 | $988 | $55 |
| Lamotrigine | 46 | $914 | $20 |
| Oxcarbazepine | 22 | $789 | $36 |
| Midodrine | 11 | $734 | $67 |
| Duloxetine | 13 | $659 | $51 |
| Baclofen | 20 | $632 | $32 |
| Hydrocodone-Acetaminophen | 39 | $629 | $16 |
| Clopidogrel | 55 | $613 | $11 |
| Escitalopram | 68 | $608 | $9 |
| Clonazepam | 71 | $596 | $8 |
| Sumatriptan | 42 | $582 | $14 |
| Rizatriptan | 12 | $511 | $43 |
| Dextroamphetamine-Amphetamine | 20 | $467 | $23 |
| Topiramate | 28 | $455 | $16 |
| Prednisone | 34 | $446 | $13 |
| Fludrocortisone Acetate | 16 | $425 | $27 |
| Amitriptyline | 16 | $409 | $26 |
| Alprazolam | 39 | $406 | $10 |
| Quetiapine | 38 | $379 | $10 |
| Divalproex | 16 | $371 | $23 |
| Nortriptyline | 20 | $349 | $17 |
| Mirtazapine | 18 | $335 | $19 |
| Atorvastatin | 33 | $318 | $10 |
| Venlafaxine Hcl Er | 19 | $256 | $13 |
| Methadone | 13 | $214 | $16 |
| Haloperidol | 20 | $207 | $10 |
| Zonisamide | 14 | $201 | $14 |
| Sertraline | 18 | $196 | $11 |
| Oxycodone | 11 | $164 | $15 |
| Lorazepam | 24 | $116 | $5 |
| Tramadol | 13 | $110 | $8 |
| Triamterene-Hydrochlorothiazid | 14 | $104 | $7 |
| Estradiol | 12 | $61 | $5 |
| Fluoxetine | 12 | $19 | $2 |
2016: 50 drugs
| Namenda Xr | 15 | $11,771 | $785 |
| Vimpat | 14 | $9,320 | $666 |
| Lyrica | 13 | $8,177 | $629 |
| Gabapentin | 149 | $4,706 | $32 |
| Memantine | 61 | $2,643 | $43 |
| Acetazolamide | 28 | $2,194 | $78 |
| Carbidopa-Levodopa | 63 | $1,757 | $28 |
| Endocet | 12 | $1,748 | $146 |
| Hydrocodone-Acetaminophen | 54 | $1,504 | $28 |
| Levetiracetam | 45 | $1,419 | $32 |
| Amitriptyline | 23 | $1,296 | $56 |
| Ziprasidone | 11 | $1,230 | $112 |
| Donepezil | 106 | $1,218 | $11 |
| Sumatriptan | 44 | $1,046 | $24 |
| Lamotrigine | 35 | $938 | $27 |
| Oxcarbazepine | 31 | $923 | $30 |
| Dextroamphetamine-Amphetamine | 11 | $916 | $83 |
| Baclofen | 19 | $895 | $47 |
| Clonazepam | 94 | $791 | $8 |
| Bupropion Xl | 18 | $779 | $43 |
| Phenytoin Sodium Extended | 16 | $659 | $41 |
| Protriptyline | 11 | $634 | $58 |
| Topiramate | 31 | $578 | $19 |
| Escitalopram | 58 | $546 | $9 |
| Carbidopa-Levodopa Er | 18 | $513 | $28 |
| Oxycodone-Acetaminophen | 18 | $512 | $28 |
| Phenobarbital | 11 | $460 | $42 |
| Temazepam | 12 | $409 | $34 |
| Clopidogrel | 36 | $391 | $11 |
| Ropinirole | 19 | $363 | $19 |
| Quetiapine | 32 | $349 | $11 |
| Prednisone | 21 | $347 | $17 |
| Alprazolam | 42 | $344 | $8 |
| Pramipexole Dihydrochloride | 27 | $334 | $12 |
| Zonisamide | 23 | $328 | $14 |
| Venlafaxine Hcl Er | 24 | $262 | $11 |
| Nortriptyline | 20 | $258 | $13 |
| Trazodone | 11 | $240 | $22 |
| Methadone | 14 | $225 | $16 |
| Propranolol | 12 | $190 | $16 |
| Methylprednisolone | 11 | $175 | $16 |
| Divalproex | 13 | $162 | $12 |
| Atorvastatin | 19 | $148 | $8 |
| Fluoxetine | 22 | $135 | $6 |
| Rizatriptan | 14 | $119 | $8 |
| Tramadol | 15 | $99 | $7 |
| Lorazepam | 18 | $97 | $5 |
| Estradiol | 12 | $87 | $7 |
| Meloxicam | 17 | $77 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $67 | $6 |
2015: 51 drugs
| Avonex | 13 | $65,996 | $5,077 |
| Keppra | 11 | $14,492 | $1,317 |
| Lyrica | 13 | $9,929 | $764 |
| Namenda | 17 | $7,989 | $470 |
| Gabapentin | 138 | $4,074 | $30 |
| Acetazolamide | 27 | $2,675 | $99 |
| Carbidopa-Levodopa | 61 | $2,556 | $42 |
| Ziprasidone | 13 | $2,065 | $159 |
| Duloxetine | 17 | $2,039 | $120 |
| Pramipexole Dihydrochloride | 31 | $1,639 | $53 |
| Hydrocodone-Acetaminophen | 47 | $1,340 | $29 |
| Naratriptan | 27 | $1,325 | $49 |
| Propranolol Hcl Er | 16 | $1,086 | $68 |
| Amitriptyline | 43 | $942 | $22 |
| Clonazepam | 92 | $933 | $10 |
| Bupropion Xl | 15 | $884 | $59 |
| Levetiracetam | 29 | $846 | $29 |
| Lamotrigine | 50 | $835 | $17 |
| Baclofen | 29 | $759 | $26 |
| Memantine | 11 | $747 | $68 |
| Phenytoin Sodium Extended | 19 | $727 | $38 |
| Oxcarbazepine | 29 | $698 | $24 |
| Carbidopa-Levodopa Er | 16 | $695 | $43 |
| Oxycodone-Acetaminophen | 17 | $622 | $37 |
| Desipramine | 11 | $596 | $54 |
| Divalproex | 12 | $564 | $47 |
| Phenobarbital | 21 | $450 | $21 |
| Topiramate | 25 | $413 | $17 |
| Temazepam | 20 | $366 | $18 |
| Donepezil | 37 | $339 | $9 |
| Nortriptyline | 27 | $323 | $12 |
| Prednisone | 20 | $270 | $14 |
| Quetiapine | 17 | $267 | $16 |
| Sumatriptan | 19 | $242 | $13 |
| Methadone | 15 | $241 | $16 |
| Propranolol | 12 | $229 | $19 |
| Escitalopram | 23 | $228 | $10 |
| Oxycodone | 13 | $223 | $17 |
| Zonisamide | 16 | $216 | $14 |
| Methylprednisolone | 11 | $208 | $19 |
| Zolpidem | 13 | $208 | $16 |
| Atorvastatin | 12 | $202 | $17 |
| Alprazolam | 31 | $192 | $6 |
| Paroxetine | 13 | $159 | $12 |
| Ropinirole | 11 | $156 | $14 |
| Mirtazapine | 11 | $149 | $14 |
| Tramadol | 23 | $134 | $6 |
| Fluoxetine | 18 | $108 | $6 |
| Lorazepam | 21 | $78 | $4 |
| Sertraline | 11 | $69 | $6 |
| Diazepam | 11 | $33 | $3 |
2014: 15 drugs
| Namenda | 13 | $6,477 | $498 |
| Lyrica | 14 | $3,319 | $237 |
| Gabapentin | 62 | $2,152 | $35 |
| Carbidopa-Levodopa | 29 | $2,137 | $74 |
| Carbidopa-Levodopa Er | 18 | $1,174 | $65 |
| Clonazepam | 43 | $758 | $18 |
| Hydrocodone-Acetaminophen | 42 | $713 | $17 |
| Levetiracetam | 16 | $690 | $43 |
| Topiramate | 23 | $567 | $25 |
| Amitriptyline | 28 | $349 | $12 |
| Lamotrigine | 13 | $283 | $22 |
| Nortriptyline | 20 | $242 | $12 |
| Phenobarbital | 13 | $188 | $14 |
| Prednisone | 13 | $141 | $11 |
| Zolpidem | 17 | $67 | $4 |
Money from drug and device companies
$140 in 2024
| 2024 | 1 | 2 | None | $140 |
| 2023 | 1 | 1 | None | $23 |
| 2019 | 1 | 3 | None | $176 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Ultomiris | $140 | 2 payments
|
See all 2 published payments
| Alexion Pharmaceuticals | Meals · 2024-05-02 | Ultomiris | $125 |
| Alexion Pharmaceuticals | Education · 2024-04-10 | Ultomiris | $15 |
See earlier years (2023, 2019)
2023: $23
| Pfizer | Paxlovid | $23 | 1 payment
|
2019: $176
| Teva Pharmaceuticals USA | Ajovy | $176 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1205951688
- Licence
- CA A25104California A25104: Current · expires 2028-06-30
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 1971
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 800 Pollard Road, Suite B 203, Los Gatos, CA, 95032
- NPI first listed
- 2007-03-21
- NPI last updated
- 2018-11-30
This is when the NPI record was last certified, not a medical board exam.